PharmTech Drug Digest 11.20
|Articles|April 2, 2018

Pharmaceutical Technology

  • Pharmaceutical Technology-04-02-2018
  • Volume 42
  • Issue 4

Additional Certifications for Touchscreen Panels

Ross Systems and Controls (SysCon) touchscreen purged panels have been certified under the standards of Underwriters Laboratories’ (UL)-698A Code and the National Fire Protection Association’s (NFPA)-496 Code.

Ross Systems and Controls (SysCon) touchscreen purged panels for Ross, Charles & Son’s mixers, blenders, and other types of equipment and processes have been certified under the standards of Underwriters Laboratories’ (UL)-698A Code and the National Fire Protection Association’s (NFPA)-496 Code. The new certifications are in addition to UL-508A (non-hazardous control panels).

The UL-698A certification involves industrial control panels designed for hazardous locations, including the use of safe barriers. NFPA-496 standards relate to purged and pressurized enclosures.

According to the company, purge systems, which are an alternative to traditional National Electrical Manufacturers Association (NEMA) standards 7 and 9 explosion proof enclosures, are suited for most hazardous locations, including class I, division I and II for gas and vapor environments as well as class II, division I and II for dust environments. Purge panel enclosures can be NEMA 4 carbon steel or NEMA 4x stainless steel depending upon regulatory or aesthetic requirements, the company reports.

Ross, Charles & Son

Articles in this issue


Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.